LIMN 8-K: Executive departure
Filed with the SEC on · accession 0001104659-26-129711
LIMN filed a 8-K (current report) with the SEC on Nov 18, 2026. Liminatus Pharma appointed Eric Sunghee Kang as Chief Corporate Strategist, effective November 16, 2026.
Summary of the filing
Liminatus Pharma appointed Eric Sunghee Kang as Chief Corporate Strategist, effective November 16, 2026. He will report to CEO Chris Kim and assist with corporate finance, capital markets strategy, and new business initiatives, without receiving compensation.
Key details
✦ Ask GOAX AI about this filing — what it means for LIMN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for LIMN?
Click hereFrequently asked questions
What did LIMN file with the SEC on Nov 18, 2026?
LIMN filed a 8-K (Executive departure). Liminatus Pharma appointed Eric Sunghee Kang as Chief Corporate Strategist, effective November 16, 2026. He will report to CEO Chris Kim and assist with corporate finance, capital markets strategy, and new business initiatives, without receiving compensation.
What does a executive departure mean for LIMN stock?
Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other LIMN SEC filings
Get alerts when LIMN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days